Patents by Inventor Mathieu Picardeau

Mathieu Picardeau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Live attenuated heterologous vaccine for
    Patent number: 11497802
    Abstract: The present invention provides compositions or vaccines that contain a recombinant or an attenuated Leptospira interrogans that elicit an immune response in animals against Leptospira infection, including compositions comprising said recombinant or attenuated L. interrogans, methods of vaccination against Leptospira, and kits for use with such methods and compositions.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: November 15, 2022
    Inventors: Natalia Ines Bomchil, Lionel Pierre Cupillard, Celia Fontana, Pierre-Michel Guigal, Jerome Bouvet, Mathieu Picardeau, Angeli Kodjo
  • immunoprotective proteins and methods of identification and use thereof
    Patent number: 10525117
    Abstract: The present invention provides compositions and methods for eliciting heterologous protective immunity in animals against Leptospira spp. The Leptospira spp. immunoprotective peptides disclosed herein elicit protective immunity against subsequent challenge or exposure to at least two Leptospira spp. serovars.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: January 7, 2020
    Inventors: Natalia Ines Bomchil, Jean-Baptiste Claude, Lionel Pierre Christian Cupillard, Célia Fontana, Anass Jawhari, Elodie Mandon, Angeli Kodjo, Mathieu Picardeau, Azad Eshghi
  • Use of serovar hurstbridge bacteria for diagnosing leptospirosis
    Patent number: 10175236
    Abstract: The present invention discloses an in vitro method for diagnosing a Leptospira infection in a biological sample of a subject, comprising a step of contacting said sample with bacterial cells of a serovar of the Leptospira fainei species, preferably bacterial cells of the Leptospira fainei serovar Hurstbridge, or an antigenic fraction of said bacterial cells. In a preferred embodiment, said Leptospira infection is not due to bacteria belonging to the serovar of the Leptospira fainei species used in the diagnostic method.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: January 8, 2019
    Assignee: Institut Pasteur
    Inventors: Pascale Bourhy, Suzanne Chanteau, Cyrille Goarant, Mathieu Picardeau, Faradibano Nato, Sylvie Dartevelle
  • Live Attenuated Heterologous Vaccine for Leptospira
    Publication number: 20180271966
    Abstract: The present invention provides compositions or vaccines that contain a recombinant or an attenuated Leptospira interrogans that elicit an immune response in animals against Leptospira infection, including compositions comprising said recombinant or attenuated L. interrogans, methods of vaccination against Leptospira, and kits for use with such methods and compositions.
    Type: Application
    Filed: October 5, 2016
    Publication date: September 27, 2018
    Inventors: Natalia Ines Bomchil, Lionel Pierre Cupillard, Celia Fontana, Pierre-Michel Guigal, Jerome Bouvet, Mathieu Picardeau, Angeli Kodjo
  • USE OF LEPTOSPIRA FAINEI SEROVAR HURSTBRIDGE BACTERIA FOR DIAGNOSING LEPTOSPIROSIS
    Publication number: 20170292951
    Abstract: The present invention discloses an in vitro method for diagnosing a Leptospira infection in a biological sample of a subject, comprising a step of contacting said sample with bacterial cells of a serovar of the Leptospira fainei species, preferably bacterial cells of the Leptospira fainei serovar Hurstbridge, or an antigenic fraction of said bacterial cells. In a preferred embodiment, said Leptospira infection is not due to bacteria belonging to the serovar of the Leptospira fainei species used in the diagnostic method.
    Type: Application
    Filed: June 21, 2017
    Publication date: October 12, 2017
    Applicant: INSTITUT PASTEUR
    Inventors: Pascale BOURHY, Suzanne CHANTEAU, Cyrille GOARANT, Mathieu PICARDEAU, Faradibano NATO, Sylvie DARTEVELLE
  • Use of serovar hurstbridge bacteria for diagnosing
    Patent number: 9714944
    Abstract: The present invention discloses an in vitro method for diagnosing a Leptospira infection in a biological sample of a subject, comprising a step of contacting said sample with bacterial cells of a serovar of the Leptospira fainei species, preferably bacterial cells of the Leptospira fainei serovar Hurstbridge, or an antigenic fraction of said bacterial cells. In a preferred embodiment, said Leptospira infection is not due to bacteria belonging to the serovar of the Leptospira fainei species used in the diagnostic method.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: July 25, 2017
    Assignee: INSTITUT PASTEUR
    Inventors: Pascale Bourhy, Suzanne Chanteau, Cyrille Goarant, Mathieu Picardeau, Faradibano Nato, Sylvie Dartevelle
  • Leptospira Immunoprotective Proteins and Methods of Identification and Use Thereof
    Publication number: 20170021004
    Abstract: The present invention provides compositions and methods for eliciting heterologous protective immunity in animals against Leptospira spp. The Leptospira spp. immunoprotective peptides disclosed herein elicit protective immunity against subsequent challenge or exposure to at least two Leptospira spp. serovars.
    Type: Application
    Filed: February 22, 2016
    Publication date: January 26, 2017
    Applicants: MERIAL, INC., CALIXAR, GENOSTAR, VETAGRO-SUP, INSTITUT PASTEUR
    Inventors: Natalia Ines Bomchil, Jean-Baptiste Claude, Lionel Pierre Christian Cupillard, Célia Fontana, Anass Jawhari, Elodie Mandon, Angeli Kodjo, Mathieu Picardeau, Azad Eshghi
  • USE OF LEPTOSPIRA FAINEI SEROVAR HURSTBRIDGE BACTERIA FOR DIAGNOSING LEPTOSPIROSIS
    Publication number: 20150253325
    Abstract: The present invention discloses an in vitro method for diagnosing a Leptospira infection in a biological sample of a subject, comprising a step of contacting said sample with bacterial cells of a serovar of the Leptospira fainei species, preferably bacterial cells of the Leptospira fainei serovar Hurstbridge, or an antigenic fraction of said bacterial cells. In a preferred embodiment, said Leptospira infection is not due to bacteria belonging to the serovar of the Leptospira fainei species used in the diagnostic method.
    Type: Application
    Filed: October 4, 2013
    Publication date: September 10, 2015
    Inventors: Pascale Bourhy, Suzanne Chanteau, Cyrille Goarant, Mathieu Picardeau, Faradibano Nato, Sylvie Dartevelle